125 related articles for article (PubMed ID: 36806557)
21. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
22. m
Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J
Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206
[TBL] [Abstract][Full Text] [Related]
23.
Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
[TBL] [Abstract][Full Text] [Related]
24. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
25. Histone-modifying genes as biomarkers in hepatocellular carcinoma.
Hung SY; Lin HH; Yeh KT; Chang JG
Int J Clin Exp Pathol; 2014; 7(5):2496-507. PubMed ID: 24966962
[TBL] [Abstract][Full Text] [Related]
26. Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma.
Piao L; Yuan X; Zhuang M; Qiu X; Xu X; Kong R; Liu Z
Oncol Rep; 2019 Jan; 41(1):325-332. PubMed ID: 30542727
[TBL] [Abstract][Full Text] [Related]
27. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
[TBL] [Abstract][Full Text] [Related]
28. Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma.
Miao Y; Liu G; Liu L
Cancer Cell Int; 2021 Jan; 21(1):2. PubMed ID: 33397384
[TBL] [Abstract][Full Text] [Related]
29. Histone methyltransferase SUV39H2 regulates cell growth and chemosensitivity in glioma via regulation of hedgehog signaling.
Wang R; Cheng L; Yang X; Chen X; Miao Y; Qiu Y; Zhou Z
Cancer Cell Int; 2019; 19():269. PubMed ID: 31636512
[TBL] [Abstract][Full Text] [Related]
30. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
[TBL] [Abstract][Full Text] [Related]
31. Activity and specificity of the human SUV39H2 protein lysine methyltransferase.
Schuhmacher MK; Kudithipudi S; Kusevic D; Weirich S; Jeltsch A
Biochim Biophys Acta; 2015 Jan; 1849(1):55-63. PubMed ID: 25459750
[TBL] [Abstract][Full Text] [Related]
32. Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.
Zheng Y; Li B; Wang J; Xiong Y; Wang K; Qi Y; Sun H; Wu L; Yang L
Clin Epigenetics; 2018 Oct; 10(1):129. PubMed ID: 30348215
[TBL] [Abstract][Full Text] [Related]
33. Investigation of H2AX methylation by the SUV39H2 protein lysine methyltransferase.
Schuhmacher MK; Kudithipudi S; Jeltsch A
FEBS Lett; 2016 Jun; 590(12):1713-9. PubMed ID: 27177470
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
35. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
36. LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer.
Gao Z; Long Y; Wu Y; Pu Y; Xue F
Carcinogenesis; 2022 Jun; 43(5):419-429. PubMed ID: 35136989
[TBL] [Abstract][Full Text] [Related]
37. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
38. m
Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
[TBL] [Abstract][Full Text] [Related]
39. Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer.
Yoon KA; Hwangbo B; Kim IJ; Park S; Kim HS; Kee HJ; Lee JE; Jang YK; Park JG; Lee JS
Carcinogenesis; 2006 Nov; 27(11):2217-22. PubMed ID: 16774942
[TBL] [Abstract][Full Text] [Related]
40. METTL3 potentiates resistance to cisplatin through m
Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
